0001415889-24-006823.txt : 20240305
0001415889-24-006823.hdr.sgml : 20240305
20240305180027
ACCESSION NUMBER: 0001415889-24-006823
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Nicholas Conrad
CENTRAL INDEX KEY: 0002009130
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41944
FILM NUMBER: 24722919
MAIL ADDRESS:
STREET 1: C/O ALTO NEUROSCIENCE, INC.
STREET 2: 369 SOUTH SAN ANTONIO ROAD
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alto Neuroscience, Inc.
CENTRAL INDEX KEY: 0001999480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 834210124
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 369 SOUTH SAN ANTONIO RD.
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 773-255-5012
MAIL ADDRESS:
STREET 1: 369 SOUTH SAN ANTONIO RD.
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
4
1
form4-03052024_060303.xml
X0508
4
2024-03-01
0001999480
Alto Neuroscience, Inc.
ANRO
0002009130
Smith Nicholas Conrad
C/O ALTO NEUROSCIENCE, INC.
369 SOUTH SAN ANTONIO ROAD
LOS ALTOS
CA
94022
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Common Stock
2024-03-01
4
A
0
19153
0
A
20716
D
Employee Stock Option (Right to Buy)
14.88
2024-03-01
4
A
0
90000
0
A
2034-02-28
Common Stock
90000
90000
D
Represents a restricted stock unit ("RSU") award. The RSUs shall vest in two equal installments on September 1, 2025 and March 1, 2026, subject to the Reporting Person's continuous service through each such vesting date.
Each RSU represents a contingent right to receive one share of common stock.
25% of the shares underlying the option shall vest on March 1, 2025, and one forty-eighth (1/48th) of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
/s/ Erin R. McQuade, Attorney-in-Fact
2024-03-05